trial · primary record
sorafenib tosylate
Adult Primary Hepatocellular Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 73 |
| Primary completion | 2023-02 |
| Primary endpoint | Recurrence-free Survival at 2 Years |
| Registry ID | NCT01624285 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:34.111Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01624285
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.